Trial Profile

Phase 1 Study to Determine the Immunomodulatory Activity of LY2157299 Monohydrate in Patients with Solid Tumors

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 07 Oct 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Galunisertib (Primary)
Indications Solid tumours
Focus Pharmacodynamics
Sponsors Eli Lilly and Company

Most Recent Events

04 Oct 2016 Status changed from active, no longer recruiting to completed.
25 Aug 2016 Planned End Date changed from 1 Jun 2018 to 1 Dec 2016.
25 Aug 2016 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2016.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com